MetLysBradykinin CAS 550196 Factory and Reliable Suppliers in China

<p>High-purity Met-Lys-Bradykinin (CAS 550-19-6) supplied by a leading China factory. This potent B2 receptor agonist is ideal for pharmacological research into the kallikrein-kinin system. Contact our expert suppliers for GMP-grade peptide powders and global shipping.</p>

SupplierGlobal Technology Co., Ltd.www.hqtechtirz.com

View on supplier website More from this supplier

Source categories

Hot Products

About this product

Product information from the supplier.

Met-Lys-Bradykinin (CAS NO.550-19-6) is a high-purity bradykinin analog and potent B2 receptor agonist designed for advanced biomedical research. By specifically interacting with the B2 subtype of bradykinin receptors, this peptide triggers essential intracellular signaling cascades, making it an indispensable tool for studying vasodilation, inflammatory responses, and vascular permeability in preclinical pharmacological models.

Engineered for stability and precision, Met-Lys-Bradykinin serves as a critical pharmacological probe for evaluating receptor binding affinity and selectivity. It is widely utilized in GPCR signaling research, calcium flux assays, and drug discovery pipelines aimed at modulating the kallikrein-kinin system for the treatment of cardiovascular and inflammatory disorders.

Detailed Parameters

Product Name	Met-Lys-Bradykinin	CAS NO.	550-19-6
Molecular Formula	C61H94N18O13S	Molecular Weight	1319.61 g/mol
Purity (RP-HPLC)	≥99.0%	Appearance	White to off-white powder
Solubility	Water, dilute acetic acid	Endotoxin	≤1.0 EU/mg
Storage	-20°C, dry, dark container	Stock Location	USA

Key Advantages

Ultra-High Purity

Guaranteed ≥99.0% purity via RP-HPLC, ensuring consistent and reproducible results in sensitive receptor assays.

Enhanced Stability

Unique N-terminal structure provides improved metabolic stability against peptidases compared to native Bradykinin.

Precise Agonism

Specifically targets B2 receptors to stimulate nitric oxide synthesis and smooth muscle relaxation.

Validated Activity

Proven efficacy in inducing vascular permeability and prostaglandin synthesis in endothelial cells.

Low Endotoxin

Maintained at ≤1.0 EU/mg, minimizing non-specific cellular responses in in vitro research.

Full Traceability

Each batch includes COA, MS chromatograms, and HPLC reports for total quality transparency.

Product Gallery

Management Platforms

GMP Production

Strict adherence to GMP-compliant systems for synthesis and purification processes.

QC Validation

Standardized quality control covering raw materials to final packaging.

Cold Chain Logic

Specialized -20°C storage and shipping to maintain peptide biological activity.

Global Logistics

Fast international air freight via DHL, FedEx, and UPS for rapid delivery.

Scale Flexibility

Capabilities ranging from gram-level research samples to ton-level industrial supply.

Regulatory Compliance

Compliant with international trade standards and pharmaceutical API regulations.

Investment Return Comparison

Metric	Standard Grade	GlobalTech Premium Grade
Purity Level	≥95.0%	≥99.0% (HPLC Verified)
Metabolic Stability	Low / Native	High / Modified N-terminal
Endotoxin Control	Not Specified	Strictly ≤1.0 EU/mg
Documentation	Basic COA	Full COA, MS, and HPLC Reports
Delivery Speed	Standard Shipping	Express USA-based Stocking

Frequently Asked Questions

Q: What are the primary research applications for Met-Lys-Bradykinin?

It is primarily used for in vitro laboratory research, receptor binding assays, and preclinical studies on the kininergic system, specifically targeting the B2 receptor to study inflammation and vasodilation.

Q: How does Met-Lys-Bradykinin differ from native Bradykinin?

Met-Lys-Bradykinin features a modified N-terminal structure that enhances its metabolic stability and alters its interaction with enzymes like ACE, providing a more reliable probe for research.

Q: What are the recommended storage conditions for this peptide?

The product should be stored at -20°C in a dry, dark, and well-sealed container. It is crucial to avoid repeated freeze-thaw cycles to preserve biological activity.

Q: Is this product suitable for clinical use in humans?

No. Met-Lys-Bradykinin is strictly designated for in vitro laboratory research and preclinical pharmacological studies; it is not a clinical therapeutic agent.

Q: What quality certifications accompany the shipment?

Every batch comes with a comprehensive Certificate of Analysis (COA), RP-HPLC purity reports, and mass spectrometry (MS) chromatograms to verify identity and purity.

Q: How is the product shipped to ensure stability?

We use professional secure packaging with temperature-controlled solutions and fast international air freight (DHL/FedEx/UPS) to minimize environmental exposure.